Target intelligence / Profile preview

Nematode muscle gamma-aminobutyric acid receptor (UNC-49) (UNC-49)

Target
UNC-49
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor family, Receptor
01

Overview

The nematode muscle GABA receptor, primarily represented by the UNC-49 complex, is a ligand-gated chloride channel essential for inhibitory signaling at the neuromuscular junction (Bamber et al., 1999). In nematodes such as Caenorhabditis elegans and Ascaris suum, this receptor mediates muscle relaxation, which is critical for the undulating movement and locomotion of the organism (Raymond et al., 2000). It is a member of the Cys-loop receptor superfamily and typically functions as a heteromer composed of different subunits (e.g., UNC-49B and UNC-49C) that provide distinct pharmacological properties (Bamber et al., 1999). This receptor is a major target for anthelmintic drugs such as piperazine, which acts as a selective GABA agonist to induce flaccid paralysis in the parasite, allowing it to be expelled from the host's body (Martin, 1997). Understanding the structural and functional differences between nematode UNC-49 receptors and vertebrate GABA_A receptors is crucial for developing selective antiparasitic agents with minimal host toxicity (Accardi et al., 2012).

Other names
Nematode muscle GABA_A receptorUNC-49 receptorNematode GABA-gated chloride channelGABA-A-like nematode receptor
02

Mechanism of action

Agonists bind to the receptor complex at the neuromuscular junction, triggering the opening of an integral chloride-selective pore. The resulting influx of chloride ions hyperpolarizes the muscle cell membrane, inhibiting contraction and leading to flaccid paralysis of the nematode (Martin, 1997; Bamber et al., 1999).

03

Biological functions

Inhibitory neurotransmissionMuscle relaxationLocomotion regulationChloride ion transport
04

Disease associations

HelminthiasisAscariasisParasitic infection
05

Safety considerations

Potential cross-reactivity with vertebrate GABA_A receptors if drug selectivity is insufficientDevelopment of anthelmintic resistance through subunit mutations (Accardi et al., 2012)Species-specific variations in subunit composition affecting drug efficacy
06

Interacting drugs

Piperazine

4 more in the full profile.

07

Biomarkers

Reduction in fecal egg count (FECR)Parasite motility inhibition assaysElectrophysiological response in nematode muscle cells

Beyond the preview

Go deeper on Nematode muscle gamma-aminobutyric acid receptor (UNC-49) (UNC-49).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nematode muscle gamma-aminobutyric acid receptor (UNC-49) (UNC-49).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call